Thursday, 19 April 2012


Roche ready to walk away from $6.8 billion Illumina bid

ZURICH/NEW YORK (Reuters) - Swiss drugmaker Roche said on Wednesday it would not extend a $6.8 billion hostile offer for genetic specialist Illumina as the U.S. group's shareholders blocked its move to appoint new directors. Roche, which is no... read more..

No comments:

Post a Comment